Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Motolese

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1984
Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in manC A Sorbini, V Grassi, C Tantucci, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Blunting of atrial natriuretic factor response to volume expansion by benazepril in hypertensive patientsP Dessì-Fulgheri, M Motolese, G Di Noto, et al.
Journal of Cardiovascular Pharmacology|November 20, 1998
Benazepril causes in hypertension a greater reduction in left ventricular mass than does nitrendipine: a randomized study using magnetic resonance imagingC Gaudio, G Tanzilli, F M Ferri, et al.
Giornale Italiano Di Cardiologia|February 1, 1984
[Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day]R Fariello, C Alicandri, E Boni, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|January 22, 2002
An Italian chart for cardiovascular risk prediction. Its scientific basisA Menotti, M Lanti, P E Puddu, et al.
Cardiology|January 1, 1983
Relationships between plasma catecholamines, renin, age and blood pressure in essential hypertensionE Agabiti-Rosei, C Alicandri, M Beschi, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1980
Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertensionM Motolese, E Agabiti-Rosei, A Carotti, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1993
Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoringP Palatini, L Mos, M Motolese, et al.
European Heart Journal|February 13, 2003
Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesionsF Prati, E Arbustini, A Labellarte, et al.
The New England Journal of Medicine|April 11, 1996
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study GroupG Maschio, D Alberti, G Janin, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1984
Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in manC A Sorbini, V Grassi, C Tantucci, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Blunting of atrial natriuretic factor response to volume expansion by benazepril in hypertensive patientsP Dessì-Fulgheri, M Motolese, G Di Noto, et al.
Journal of Cardiovascular Pharmacology|November 20, 1998
Benazepril causes in hypertension a greater reduction in left ventricular mass than does nitrendipine: a randomized study using magnetic resonance imagingC Gaudio, G Tanzilli, F M Ferri, et al.
Giornale Italiano Di Cardiologia|February 1, 1984
[Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day]R Fariello, C Alicandri, E Boni, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|January 22, 2002
An Italian chart for cardiovascular risk prediction. Its scientific basisA Menotti, M Lanti, P E Puddu, et al.
Cardiology|January 1, 1983
Relationships between plasma catecholamines, renin, age and blood pressure in essential hypertensionE Agabiti-Rosei, C Alicandri, M Beschi, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1980
Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertensionM Motolese, E Agabiti-Rosei, A Carotti, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1993
Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoringP Palatini, L Mos, M Motolese, et al.
European Heart Journal|February 13, 2003
Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesionsF Prati, E Arbustini, A Labellarte, et al.
The New England Journal of Medicine|April 11, 1996
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study GroupG Maschio, D Alberti, G Janin, et al.
Pageof 8